H. Brüssow

发表

Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic

H. Brüssow, Lutz Brüssow, 2021, Microbial biotechnology.

What we can learn from the dynamics of the 1889 ‘Russian flu’ pandemic for the future trajectory of COVID‐19

H. Brüssow, 2021, Microbial biotechnology.

Host‐modifying drugs against COVID‐19: some successes, but not yet the breakthrough

H. Brüssow, 2021, Environmental microbiology.

Clinical trials with antiviral drugs against COVID‐19: some progress and many shattered hopes

H. Brüssow, 2021, Environmental microbiology.

COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2

H. Brüssow, 2022, Microbial biotechnology.

On the role of hypotheses in science

H. Brüssow, 2022, Microbial biotechnology.

On opinion, freedom of speech and its responsibilities

H. Brüssow, 2022, Microbial biotechnology.

COVID‐19 and children: medical impact and collateral damage

Harald Brüssow, H. Brüssow, 2022, Microbial biotechnology.

Can a combination of vaccination and face mask wearing contain the COVID‐19 pandemic?

S. Zuber, H. Brüssow, 2021, Microbial biotechnology.

The beginning and ending of a respiratory viral pandemic‐lessons from the Spanish flu

H. Brüssow, 2022, Microbial biotechnology.

Changing Epidemiology of Acute Respiratory Infections in Under-Two Children in Dhaka, Bangladesh

T. Ahmed, S. Sarker, O. Sakwinska, 2022, Frontiers in Pediatrics.

mRNA vaccines against COVID‐19: a showcase for the importance of microbial biotechnology

H. Brüssow, 2021, Microbial biotechnology.

The Influence of FUT2 and FUT3 Polymorphisms and Nasopharyngeal Microbiome on Respiratory Infections in Breastfed Bangladeshi Infants from the Microbiota and Health Study

H. Nielsen, Gregory Lefebvre, A. Eklund, 2021, mSphere.

Microbiota and Health Study: a prospective cohort of respiratory and diarrheal infections and associated risk factors in Bangladeshi infants under two years

S. Sarker, O. Sakwinska, Mahbubur Rahman, 2019, medRxiv.

Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?

H. Brüssow, 2022, Microbial biotechnology.

Glycosphingolipid Binding Specificities of Rotavirus: Identification of a Sialic Acid-Binding Epitope

N. Roche, S. Teneberg, K. Karlsson, 2001, Journal of Virology.

Epidemiology of rotavirus gastroenteritis in infants from the area of Bochum as revealed by electrophoresis of genome RNA

B. Grunert, C. Houly, H. Brüssow, 1984, European Journal of Pediatrics.

Faculty Opinions recommendation of SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

H. Brüssow, 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

Pandemic potential of poxviruses: From an ancient killer causing smallpox to the surge of monkeypox

H. Brüssow, 2023, Microbial biotechnology.

Viral infections at the animal–human interface—Learning lessons from the SARS‐CoV‐2 pandemic

H. Brüssow, 2023, Microbial biotechnology.

Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis.

H. Brüssow, H. Werchau, W. Liedtke, 1988, The Journal of infectious diseases.

Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.

H. Brüssow, A. Bruttin, J. Sidoti, 1988, The Journal of general virology.

Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum.

S. Sarker, M. Albert, D. Mahalanabis, 1998, The Pediatric infectious disease journal.

Prevalence and serotype specificity of rotavirus antibodies in different age groups of Ecuadorian infants.

H. Brüssow, W. Freire, J. Sotek, 1990, The Journal of infectious diseases.

Pandemic preparedness: On the efficacy of non‐pharmaceutical interventions in COVID‐19 and about approaches to predict future pandemic viruses

H. Brüssow, 2024, Microbial biotechnology.

Antipeptide antibodies directed against the carboxy‐terminal region of SV40 structural proteins VP2 and VP3

K. Sure, H. Brüssow, H. Werchau, 1986, Journal of Cellular Biochemistry.

The human microbiome project at ten years - some critical comments and reflections on “our third genome”, the human virome

H. Brüssow, 2023, Microbiome research reports.

Avian influenza virus cross‐infections as test case for pandemic preparedness: From epidemiological hazard models to sequence‐based early viral warning systems

H. Brüssow, 2024, Microbial biotechnology.

The antibiotic resistance crisis and the development of new antibiotics

H. Brüssow, 2024, Microbial biotechnology.